Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

ERBB2 ABCA2 MAML1 BIRC6 LYST TINAGL1 FASN PIK3C2B A4GALT TIGD3 DNMBP HECTD1 ABCC10 DPH2 SEMA4B HECTD4 HIP1R DDX56 HUWE1 ARHGAP35 ADGRA2 HIVEP3 IGF2R CELSR2 NEK8 CSPG4 AKAP13 SPEN ADAT1

2.83e-1011052292935748872
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

SSRP1 DHX9 G3BP2 NUP210 MKI67 SMG9 MMS19 HECTD1 PML HECTD4 GPATCH2 DDX56 HUWE1 ZBTB1 ACTR6 THAP12 AQR

6.93e-094402291734244565
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

STARD13 MYH6 ACACB MAP1B RAB22A SSRP1 LYST PHEX FASN C9orf43 AP2A2 SNAP91 SACS FAM186A TASOR DNAH6 ANK2 PCDHGC4 PCDHGA6 SYNE1 HEATR1 NARS2 MYLK2 SF3B3 KHDRBS1 SEC62 CSPG4 ITSN2 CAPRIN2 CFAP74 SPEN

7.65e-0914422293135575683
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

RALGAPA1 ERBB2 MAP1B MYO9A SSRP1 LYST USP31 MYLK3 PIK3C2B IQSEC1 DNMBP HECTD1 CFAP97 PML STIL NARS2 MYLK2 IFRD1 VPS13D IPO9 AKAP13 AQR ARHGAP19

1.62e-088612292336931259
Pubmed

Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.

PGR MKI67 MUC16

2.82e-073229327163153
Pubmed

Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.

ERBB2 PGR MKI67

2.82e-073229325778295
Pubmed

Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients: a retrospective study.

ERBB2 PGR MKI67

2.82e-073229325170613
Pubmed

Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.

ERBB2 PGR MKI67

2.82e-073229323818347
Pubmed

Ki-67 is a prognostic marker for hormone receptor positive tumors.

ERBB2 PGR MKI67

2.82e-073229326742937
Pubmed

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

ERBB2 PGR MKI67

1.12e-064229319436038
Pubmed

An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.

ERBB2 PGR MKI67

1.12e-064229328490348
Pubmed

Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.

ERBB2 PGR MKI67

1.12e-064229323818346
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

BIRC6 PTGFRN ABCA8 USP20 SMYD4 AP2A2 SACS NUP210 HECTD1 TASOR SEMA4B ARHGAP35 HIVEP3 VPS13D IPO9

1.14e-064932291515368895
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

RALGAPA1 ERBB2 ABCA2 MAML1 ADGRV1 SMG7 DNMBP CFAP97 HECTD4 HIP1R E2F3 ADGRA2 SF3B3 PPM1F CAPRIN2

2.70e-065292291514621295
Pubmed

Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma.

ERBB2 PGR MKI67

2.79e-065229325845386
Pubmed

IRF6 and AP2A Interaction Regulates Epidermal Development.

AP2A2 MKI67 DSC3 TGM1

3.13e-0616229429913133
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

RALGAPA1 MYH6 MAP1A MAP1B MYO9A RTN3 DHX9 USP31 FASN AP2A2 SNAP91 SACS SV2A G3BP2 IQSEC1 DNAH6 KNG1 ANK2 SYNE1 ZNFX1 ARHGAP35 TGM1 SF3B3 KHDRBS1 ITSN2 ENO2

3.17e-0614312292637142655
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

STARD13 MIS18BP1 MAP1B MYO9A SSRP1 BIRC6 DHX9 FASN AP2A2 MKI67 IQSEC1 MMS19 DSC3 HIP1R DDX56 HEATR1 HUWE1 TGM1 POLR3B IPO9 SF3B3 PPM1F AKAP13 MRTO4 AQR

3.71e-0613532292529467282
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

ERBB2 ACACB MYO9A SSRP1 USP31 FAM186A GPATCH2 MUC16 STIL PPM1F NEK8 SPEN EPHA3

4.97e-064202291328065597
Pubmed

Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

DNAH6 SEMA4B SYNE1 VEPH1 FHOD3 ARHGAP35 CFAP74

5.32e-06102229711214970
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

TRPM6 CACNA2D2 RTN3 SSRP1 DHX9 FASN AP2A2 G3BP2 KCTD16 NUP210 MKI67 DNAH5 DNHD1 APMAP SYNE1 DDX56 HEATR1 HUWE1 IPO9 IGF2R SF3B3 KHDRBS1 MRTO4 SPEN AQR

9.04e-0614252292530948266
Pubmed

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

TINAGL1 FASN NUP210 DNAH5 SYNE1 ADGRA2 RNF123 IPO9 MEGF11

1.35e-05214229922199357
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

RAB22A ADGRV1 PARD6B FASN FCGBP CLIC5 HEBP1 KNG1 NAA16 MPST DNHD1 NT5E HUWE1 CR1 TGFBR3 VPS13D IGF2R CAPN7 ITSN2 SPEN

1.49e-0510162292019056867
Pubmed

N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.

ZGRF1 PLCB3 EXOG TASOR DPH2 HIP1R IPO9 CSPG4 AKAP13

1.51e-05217229934048709
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

MIS18BP1 RTN3 PTGFRN DHX9 FASN AP2A2 SV2A NUP210 MKI67 IQSEC1 PML APMAP HEATR1 IPO9 IGF2R ABCB10 SEC62 CSPG4 CENPI SUMO3 THAP12 AQR

1.72e-0512032292229180619
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

RALGAPA1 ERBB2 MAP1B CACNA2D2 MYO9A RTN3 ADGRV1 ZNF440 SMG7 RIN2 NUP210 HECTD1 APMAP HECTD4 GPATCH2 CHD9 DDX56 E2F3 HUWE1 ARHGAP35 HIVEP3 ANKRD44 IFRD1 AKAP13 ARHGEF26

1.89e-0514892292528611215
Pubmed

An Interaction Landscape of Ubiquitin Signaling.

SMYD4 AP2A2 PIK3C2B HECTD1 PML RAD23A HECTD4 DDX56 HUWE1 RNF123 KHDRBS1 ITSN2 SHARPIN

2.09e-054812291328190767
Pubmed

Auditory cortex interneuron development requires cadherins operating hair-cell mechanoelectrical transduction.

CDH23 ADGRV1 MKI67

2.30e-059229328705869
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

ERBB2 ACACB FTSJ1 PARD6B USP31 PIK3C2B DENND4B DSC3 IGF2R CELSR2 ITSN2 EPHA3

2.60e-054212291236976175
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

ACACB ZGRF1 DHX9 FAM186A DNAH5 DNHD1 SYNE1 SF3B3 KHDRBS1

2.74e-05234229936243803
Pubmed

MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.

ERBB2 MAP1B MKI67 PLAG1 SEMA4B HUWE1 STIL CELSR2 KHDRBS1 HECA EPHA3

2.86e-053582291132460013
Pubmed

Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor.

ADGRA2 CSPG4 ENG

3.27e-0510229321282641
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

MIS18BP1 MAP1A MYO9A ZGRF1 MAML1 RTN3 SMG7 PIK3C2B DNMBP PML E2F3 HUWE1 SF3B3 SPEN

4.03e-055882291438580884
Pubmed

Myosin light chain kinase and myosin phosphorylation effect frequency-dependent potentiation of skeletal muscle contraction.

MYLK3 MYLK2

4.32e-052229216299103
Pubmed

High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.

PGR MKI67

4.32e-052229225600243
Pubmed

Regulation of microtubule-associated protein 1B (MAP1B) subunit composition.

MAP1A MAP1B

4.32e-052229211002287
Pubmed

Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.

MUC16 MUC5AC

4.32e-052229222220206
Pubmed

Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors.

MKI67 ENG

4.32e-052229223244127
Pubmed

Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs.

ERBB2 FASN

4.32e-052229226107737
Pubmed

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.

MUC16 MSLN

4.32e-052229217067392
Pubmed

Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.

ERBB2 PGR

4.32e-052229226579819
Pubmed

In situ detection of CD73+ CD90+ CD105+ lineage: Mesenchymal stromal cells in human placenta and bone marrow specimens by chipcytometry.

NT5E ENG

4.32e-052229230211969
Pubmed

Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

ERBB2 FASN

4.32e-052229227714708
Pubmed

[Clinicopathological features of young patients with triple negative breast cancer].

ERBB2 PGR

4.32e-052229219838027
Pubmed

The mouse and rat MAP1B genes: genomic organization and alternative transcription.

MAP1A MAP1B

4.32e-05222929615228
Pubmed

Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.

MUC16 MUC5AC

4.32e-052229224722639
Pubmed

Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma.

MUC16 MSLN

4.32e-052229221775916
Pubmed

Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.

ERBB2 IQSEC1

4.32e-052229221966491
Pubmed

Cloning of human microtubule-associated protein 1B and the identification of a related gene on chromosome 15.

MAP1A MAP1B

4.32e-05222927806212
Pubmed

Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.

MUC16 MUC5AC

4.32e-052229218782111
Pubmed

Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis.

ERBB2 PGR

4.32e-052229220713855
Pubmed

Estrogen receptor positive operable breast cancer: does menopausal status impact on HER2 and progesterone receptor status?

ERBB2 PGR

4.32e-052229221700456
Pubmed

Expression and significance of Her2 and Ki-67 in gastric adenocarcinoma without distant metastasis: a cohort study.

ERBB2 MKI67

4.32e-052229233059614
Pubmed

Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ.

ERBB2 MKI67

4.32e-052229226317313
Pubmed

In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.

STARD13 ERBB2

4.32e-052229229218825
Pubmed

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.

ERBB2 MKI67

4.32e-052229222361634
Pubmed

Importance of Ki-67 in human epidermal growth factor receptor 2 positive breast cancer.

ERBB2 MKI67

4.32e-052229226214624
Pubmed

Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?

MUC16 MSLN

4.32e-052229223357461
Pubmed

Progesterone receptor status in determining the prognosis of estrogen receptor positive/ HER2 negative breast carcinoma patients.

ERBB2 PGR

4.32e-052229225778292
Pubmed

PML promotes MHC class II gene expression by stabilizing the class II transactivator.

CIITA PML

4.32e-052229223007646
Pubmed

Neuronal abnormalities in microtubule-associated protein 1B mutant mice.

MAP1A MAP1B

4.32e-05222928577753
Pubmed

FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration.

ERBB2 FASN

4.32e-052229226936618
Pubmed

Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.

ERBB2 PGR

4.32e-052229218629635
Pubmed

CD105/Ki67 double immunostaining expression in liver metastasis from colon carcinoma.

MKI67 ENG

4.32e-052229221655651
Pubmed

Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer.

ERBB2 FASN

4.32e-052229225433947
Pubmed

The Mass1frings mutation underlies early onset hearing impairment in BUB/BnJ mice, a model for the auditory pathology of Usher syndrome IIC.

CDH23 ADGRV1

4.32e-052229215820310
Pubmed

Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma.

MUC16 MSLN

4.32e-052229222320398
Pubmed

Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.

ERBB2 MKI67

4.32e-052229218982746
Pubmed

Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression.

ERBB2 MSLN

4.32e-052229237914528
Pubmed

Significance of HER2 and Ki-67 in Preneoplastic Lesions and Carcinoma of Gallbladder.

ERBB2 MKI67

4.32e-052229230155833
Pubmed

Serum CA125 and NSE: biomarkers of disease severity in patients with silicosis.

MUC16 ENO2

4.32e-052229224642341
Pubmed

Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.

ERBB2 PGR

4.32e-052229228416639
Pubmed

Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGFbeta receptor independent manner.

TGFBR3 ENG

4.32e-052229212568406
Pubmed

A binding domain on mesothelin for CA125/MUC16.

MUC16 MSLN

4.32e-052229219075018
Pubmed

Correlations of β-catenin, Ki67 and Her-2/neu with gastric cancer.

ERBB2 MKI67

4.32e-052229224507671
Pubmed

Characterization of endoglin and Ki-67 expression in endothelial cells from benign and malignant lesions of the uterine cervix.

MKI67 ENG

4.32e-052229219788614
Pubmed

Interaction between fatty acid synthase and human epidermal growth receptor 2 (HER2) in osteosarcoma cells.

ERBB2 FASN

4.32e-052229225674245
Pubmed

Association of estrogen receptor, progesterone receptor and HER2 following neoadjuvant systemic treatment in breast cancer patients undergoing surgery.

ERBB2 PGR

4.32e-052229223757214
Pubmed

The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas.

ERBB2 PGR

4.32e-052229220167054
Pubmed

An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.

ERBB2 PGR

4.32e-052229227377889
Pubmed

[Expression discordances and clinical values of ER, PR, HER-2 and Ki-67 in primary and metastatic breast cancer].

ERBB2 MKI67

4.32e-052229231550858
Pubmed

Heterotypic complex formation between subunits of microtubule-associated proteins 1A and 1B is due to interaction of conserved domains.

MAP1A MAP1B

4.32e-052229216996626
Pubmed

The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.

MUC16 ENO2

4.32e-052229222674301
Pubmed

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.

ERBB2 FASN

4.32e-052229215235125
Pubmed

The adaptor protein VEPH1 interacts with the kinase domain of ERBB2 and impacts EGF signaling in ovarian cancer cells.

ERBB2 VEPH1

4.32e-052229236828346
Pubmed

Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes.

ERBB2 FASN

4.32e-052229218528705
Pubmed

Delayed development of nervous system in mice homozygous for disrupted microtubule-associated protein 1B (MAP1B) gene.

MAP1A MAP1B

4.32e-05222929199175
Pubmed

Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis.

ERBB2 PGR

4.32e-052229223723333
Pubmed

Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA.

DHX9 KHDRBS1

4.32e-052229210951562
Pubmed

CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.

ERBB2 NT5E

4.32e-052229228855210
Pubmed

Steroid receptors, HER2/neu and Ki-67, in endometrioid type of endometrial carcinoma: Correlation with conventional histomorphological features of prognosis.

ERBB2 MKI67

4.32e-052229219446313
Pubmed

Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015-2018.

ERBB2 MKI67

4.32e-052229231628534
Pubmed

Expression status of fatty acid synthase (FAS) but not HER2 is correlated with the differentiation grade and prognosis of esophageal carcinoma.

ERBB2 FASN

4.32e-052229223419663
Pubmed

Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer.

MUC16 MSLN

4.32e-052229225197000
Pubmed

Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis.

ERBB2 E2F3

4.32e-052229226512919
Pubmed

Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms.

PGR PLAG1

4.32e-052229233230916
Pubmed

Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.

ERBB2 PGR

4.32e-052229221544804
Pubmed

Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma.

MUC16 MSLN

4.32e-052229232468249
Pubmed

Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis.

MUC16 MSLN

4.32e-052229233832498
Pubmed

Mitochondrial transporter ATP binding cassette mitochondrial erythroid is a novel gene required for cardiac recovery after ischemia/reperfusion.

ABCA2 ABCB10

4.32e-052229221788586
InteractionMAP1LC3A interactions

SP3 MAP1A MAP1B RTN3 BIRC6 AP2A2 PML RAD23A ANK2 IGF2R SEC62 AKAP13 PADI3

2.77e-0624122113int:MAP1LC3A
InteractionTOP3B interactions

ERBB2 ABCA2 MAML1 SSRP1 BIRC6 LYST DHX9 TINAGL1 FASN SMG7 PIK3C2B G3BP2 A4GALT TIGD3 MMS19 DNMBP HECTD1 ABCC10 DPH2 SEMA4B VEPH1 HECTD4 HIP1R DDX56 HUWE1 ARHGAP35 ADGRA2 HIVEP3 IGF2R CELSR2 NEK8 CSPG4 AKAP13 SPEN ADAT1

1.13e-05147022135int:TOP3B
InteractionMTDH interactions

SSRP1 DHX9 TINAGL1 FASN AP2A2 G3BP2 NUP210 DNAH5 HECTD1 PML SYNE1 ADGRA2 RNF123 IPO9 OTUD6B SEC62 MRTO4 MEGF11

1.25e-0550522118int:MTDH
InteractionCD160 interactions

CACNA2D2 ADGRV1 PTGFRN TCTN1 TGFBR3 CELSR2

1.36e-05482216int:CD160
GeneFamilyUPF1 like RNA helicases

ZGRF1 ZNFX1 AQR

8.45e-051114831169
GeneFamilyATP binding cassette subfamily A

ABCA2 ABCA13 ABCA8

1.83e-04141483805
GeneFamilyRho GTPase activating proteins|BCH domain containing

STARD13 GMIP ARHGAP35 ARHGAP19

7.41e-04501484721
GeneFamilyCD molecules|5'-nucleotidases

NT5E NT5C1B

1.36e-03714821042
GeneFamilyBlood group antigens|CD molecules|Proteoglycans

TGFBR3 CSPG4

1.36e-0371482570
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

DNMBP ITSN2 AKAP13 ARHGEF26

2.10e-03661484722
CoexpressionDEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN

ERBB2 ABCA2 FTSJ1 DHX9 KANK1 SV2A NUP210 MKI67 ABCC10 ARHGAP35 IGF2R CELSR2 ENO2 AQR

1.56e-0727622814M3063
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

RALGAPA1 SP3 MIS18BP1 DENND1C GMIP BIRC6 LYST USP20 DHX9 CLIC5 SACS G3BP2 DENND4B NUP210 PARP9 TASOR APMAP SYNE1 ICAM3 HECTD4 ZNFX1 HUWE1 ARHGAP35 ZBTB1 HIVEP3 ANKRD44 TGFBR3 SF3B3 KHDRBS1 ITSN2 AKAP13 SPEN THAP12 HECA

2.64e-07149222834M40023
ToppCellrenal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

ACACB LRRC37A3 ME1 TINAGL1 FCGBP MGAM ANK2 CHD9 TGFBR3 ENG

6.07e-08192228106c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCellNS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ABCA13 ADGRV1 ZNF440 DNAH5 DNAH6 TCTN1 MOK BCO2 CFAP74 HYDIN

6.37e-0819322810ea345d34440b25f65358a53dc72831998d1c3620
ToppCellnucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CACNA2D2 MYO9A ADGRV1 PGC PARD6B KANK1 CLIC5 SYNE1 VEPH1 ARHGEF26

6.69e-081942281053f3e49e91b1096f3226010e2de767efb490dfe4
ToppCellmoderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ABCA13 SSRP1 ZNF440 TCTN1 MOK NT5E STIL SYT10 BCO2 MSLN

6.69e-08194228105dffa578149104dda33774361e9e77b227b5f1ce
ToppCellnucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CACNA2D2 MYO9A ADGRV1 PGC PARD6B KANK1 CLIC5 DNAH5 SYNE1 VEPH1

7.02e-08195228109406866f99555198a9be311fbd65751b70f35446
ToppCellE18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TRPM6 ABCA2 CLIC5 PIK3C2B LRRC75A ABCC10 MOK ARHGEF26 MSLN

3.13e-071752289711ace94fa9a763c6ae48171a690953f25deebe4
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH6 MYO9A LYST DHX9 RIN2 ARRDC3 TASOR CHD9 ZBED6

3.28e-071762289749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ERBB2 MYO9A BCAT1 ME1 PARD6B CLIC5 VEPH1 SH2D3A ARHGEF26

4.15e-071812289b45b11428d13950369347e051d4d517efb2bd4fd
ToppCellAT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

STARD13 ERBB2 CACNA2D2 ABCA8 CLIC5 DUSP8 VEPH1 ARHGEF26 RAI2

4.56e-0718322896821dca076318115d360ff426eb1218cfe104063
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ABCA13 ZNF440 DNAH5 DNAH6 MOK SYNE1 MUC16 CFAP74 HYDIN

7.43e-0719422894a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCellmoderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MAP1A ZNF440 DNAH5 DNAH6 TCTN1 MOK SYNE1 CFAP74 HYDIN

7.75e-0719522893486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ABCA13 ZNF440 DNAH5 DNAH6 MOK MUC16 BCO2 CFAP74 HYDIN

7.75e-07195228979dc031258579ea328181dda33710dd897f1064a
ToppCellNS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MAP1A ZNF440 DNAH5 DNAH6 TCTN1 MOK SYNE1 CFAP74 HYDIN

8.44e-07197228971fea4aa6ce96c7693fa94792d08770622873850
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ZNF440 DNAH5 DNAH6 MOK IQCH SYNE1 BBS5 CFAP74 HYDIN

8.44e-07197228974a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCellcritical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MAP1A ZNF440 DNAH5 DNAH6 TCTN1 MOK SYNE1 CFAP74 HYDIN

8.81e-071982289ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ABCA13 RTN3 VNN1 C3AR1 MGAM APMAP SYNE1 ICAM3 IFRD1

9.18e-0719922895919933c4b842b98fc98685dc8c72c8dd32c6ea3
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CACNA2D2 MYO9A ADGRV1 PGC FASN KANK1 SYNE1 VEPH1 AKAP13

9.18e-0719922892dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ABCA13 RTN3 VNN1 C3AR1 MGAM APMAP SYNE1 ICAM3 IFRD1

9.18e-071992289caf2e050b21e7a16ce4e51b3f135debd06810231
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ERBB2 MYO9A BCAT1 ADGRV1 ME1 CLIC5 VEPH1 SH2D3A ARHGEF26

9.57e-0720022898683445ad5b70748c4a1f12eb77d47623085147e
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

RTN3 LYST VNN1 C3AR1 MGAM APMAP SYNE1 IFRD1 IGF2R

9.57e-072002289808571d74bb5c4d765ff13fc9393f88020d4e90d
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ABCA13 ZNF440 DNAH5 DNAH6 MOK MUC16 CFAP74 HYDIN

2.66e-06169228814aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCellNS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CIITA PML STIL TGM1 BCO2 ACTR6 CAPRIN2 METTL8

2.78e-061702288adf73bdc049d508f8873c22539db2ca92052a97b
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

STARD13 MAP1A SMYD4 ANK2 SYNE1 HECTD4 TGFBR3 RNF123

3.45e-0617522881d8aab491dcc27ea5dbfb6462d18ee280b21a05e
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

STARD13 MAP1A SMYD4 ANK2 SYNE1 HECTD4 TGFBR3 RNF123

3.45e-061752288427a7ee92fe16a90625946492062d37aa0f7235b
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MIS18BP1 ZGRF1 DIPK2A MKI67 MGAM IGF2R CSPG4 PADI3

3.45e-0617522883e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRPM6 CYP2E1 SSRP1 PIK3C2B DNAH6 HIP1R STIL

3.76e-06125228735042ed43045dddc341b76cc5f9fe31b5ba0abb8
ToppCellControl-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations)

CACNA2D2 ADGRV1 PGC FASN KANK1 SYNE1 VEPH1 MEGF11

4.25e-061802288198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B CLIC5 MYLK3 CCDC73 CR1 TGFBR3 ARHGEF26 ARHGAP19

4.25e-061802288d685fa2b013bc085dbef7c40956ed3043f83e483
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYO9A ABCA13 FSTL4 ADGRV1 PARD6B KCTD16 ANK2 SYT10

4.43e-0618122889d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYO9A ABCA13 FSTL4 ADGRV1 PARD6B KCTD16 ANK2 SYT10

4.61e-061822288eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SSRP1 CLIC5 PIK3C2B PARP9 DNAH6 HIP1R STIL

5.13e-061312287419a0a83b38eaea890d065c3f252ef83c2d37b5b
ToppCellCV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster

BIRC6 DIPK2A CIITA DENND4B HEATR1 HUWE1 ANKRD44 SPEN

5.20e-061852288a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCellChildren_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

BCAT1 ME1 AP2A2 CIITA FMN1 C3AR1 DNAAF9 CR1

5.20e-0618522888207f9eff113eed429e961748c6b17d672a13b33
ToppCellCV-Moderate-7|CV / Virus stimulation, Condition and Cluster

BIRC6 DIPK2A CIITA MOK HEATR1 HUWE1 ANKRD44 SPEN

5.41e-0618622888571956890fc9894d766ba294a28e376b4aba428
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ERBB2 MYO9A BCAT1 ME1 PARD6B CLIC5 VEPH1 ARHGEF26

5.41e-0618622883aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCellE16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass

MAP1B KANK1 SNAP91 ANK2 NT5E TGFBR3 RAI2 EPHA3

5.41e-061862288e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

RALGAPA1 BIRC6 HUWE1 ANKRD44 IFRD1 IGF2R ZBED6 SPEN

5.86e-061882288ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellLPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZGRF1 PGR MKI67 SDR42E1 CENPI RPE65 ARHGAP19

5.95e-0613422874d8f7ddad02fe76a614771e115ebb8e04623ba85
ToppCellCOVID-19_Convalescent-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class

FTSJ1 SMPDL3A IQSEC1 C3AR1 MMS19 PLCB3 GPATCH2 ADAT1

6.09e-0618922888b6f92ccfffc743c07201bc971b3dc1a6fa14ccc
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TRPM6 ACP6 ABCA13 RTN3 MGAM APMAP SYNE1 VEPH1

6.09e-061892288358ff514f1c8aa46067208ddf1b68396d789c130
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TRPM6 ACP6 ABCA13 RTN3 MGAM APMAP SYNE1 VEPH1

6.09e-0618922883b35022c0619df6db234613aa53a076899ca9562
ToppCellCOPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

ABCA13 ZNF440 DNAH5 DNAH6 MOK IQCH CFAP74 HYDIN

6.09e-0618922883e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCellChildren_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor

STARD13 BCAT1 ME1 AP2A2 CIITA FMN1 DNAAF9 CR1

6.33e-061902288f573fef3762a30c38cf8fa7f45df0ffbb49dc873
ToppCellnucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ABCA13 DNAH5 DNAH6 MOK IQCH MUC16 CFAP74 HYDIN

6.58e-0619122881c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCellCD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

BIRC6 LYST DIPK2A CIITA HEATR1 HUWE1 ANKRD44 SPEN

6.58e-0619122889454f642c3621370fa23640b631301346b300950
ToppCellnucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ABCA13 DNAH5 DNAH6 MOK IQCH MUC16 CFAP74 HYDIN

6.58e-061912288e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCellnucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ABCA13 DNAH5 DNAH6 MOK IQCH MUC16 CFAP74 HYDIN

6.58e-0619122889d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class

ABCA13 ZNF440 DNAH5 MOK MUC16 BCO2 CFAP74 HYDIN

6.83e-0619222889cbe961a800c981cdc742a47ed18e9c8eb6430bd
ToppCellCOPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class

ABCA13 DNAH5 DNAH6 MOK IQCH MUC16 CFAP74 HYDIN

6.83e-061922288eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCelldroplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MAP1A MAP1B CYP2E1 ME1 KCTD16 FHOD3 FREM3 TGFBR3

7.10e-0619322882b80991e7ba7640f7ab2139d30e4c54d8e533862
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

RALGAPA1 ADGRV1 BIRC6 HECTD1 HUWE1 IGF2R ZBED6 AQR

7.10e-061932288abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCelldroplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MAP1A MAP1B CYP2E1 ME1 KCTD16 FHOD3 FREM3 TGFBR3

7.10e-06193228890cfc34c2d0d7c70f071703d35db1d6037961481
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CACNA2D2 PGC LRRC14B DNAH5 DNAH6 MOK SYNE1 HYDIN

7.10e-061932288bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

STARD13 LRRC37A3 MYO9A ADGRV1 KANK1 VEPH1 HIVEP3 ANKRD44

7.94e-061962288ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellNS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MAP1A DNAH5 DNAH6 TCTN1 MOK SYNE1 CFAP74 HYDIN

7.94e-061962288d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCellPSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MAP1A DNAH5 DNAH6 TCTN1 MOK SYNE1 CFAP74 HYDIN

8.24e-0619722886865f4831eb23794fb88a8649d48d497bbae3f44
ToppCellcontrol-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MAP1A DNAH5 DNAH6 TCTN1 MOK SYNE1 CFAP74 HYDIN

8.24e-061972288e453d085182364ca347cbcc9dc995c62c3353016
ToppCellnucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

STARD13 BCAT1 AP2A2 CIITA SMPDL3A FMN1 C3AR1 CR1

8.24e-0619722886f41c8f815851968849428ec92c16745bd01a3fb
ToppCellnucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

STARD13 BCAT1 AP2A2 CIITA SMPDL3A FMN1 C3AR1 CR1

8.24e-061972288304044ace926943b8eb588f686ecbe5d1689a809
ToppCellcontrol-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MAP1A DNAH5 DNAH6 TCTN1 MOK SYNE1 CFAP74 HYDIN

8.24e-061972288d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ERBB2 BCAT1 ME1 CLIC5 VEPH1 SH2D3A FREM3 ARHGEF26

8.55e-061982288b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FCGBP CIITA VNN1 MKI67 C3AR1 MGAM STIL CENPI

8.55e-061982288732a43061d75bc5e1cf23f5056b72cd10c926668
ToppCellCOPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class

STARD13 BCAT1 AP2A2 CIITA FMN1 C3AR1 ARRDC3 DNMBP

8.87e-0619922881cf1b2d6debf9e3389f1829dcaa2857e9533a080
ToppCellParenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ERBB2 CACNA2D2 PARD6B CLIC5 VEPH1 CELSR2 ARHGEF26 MSLN

8.87e-061992288aca81a879ef9c196bd1885eff4c63ffe6c9682b7
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ERBB2 MYO9A BCAT1 ME1 CLIC5 VEPH1 SH2D3A ARHGEF26

8.87e-061992288d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCellLung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CACNA2D2 ADGRV1 PGC PARD6B FASN SYNE1 VEPH1 MSLN

9.20e-062002288c2bde99b3bc7a8740441c1a0c1394892b940b857
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CACNA2D2 ADGRV1 PGC PARD6B FASN SYNE1 VEPH1 MSLN

9.20e-0620022883ff9abd5e07780a59d5571da906fa15f00a1d5c2
ToppCellcritical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MIS18BP1 SSRP1 ASNSD1 NT5E STIL SYT10 CENPI SUMO3

9.20e-062002288f39db4250ce220a3eb58edee3f7fc3671701d46f
ToppCellParenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

CACNA2D2 ADGRV1 PGC PARD6B FASN SYNE1 VEPH1 MSLN

9.20e-0620022889970e9bde6aa2ff3aef60dcb065ff15b7463e147
ToppCell10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

RTN3 VNN1 MGAM SYNE1 ICAM3 CR1 IFRD1 IGF2R

9.20e-0620022886beabd5bad042d4d65c89c2f537c7376230f7c08
ToppCellBiopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type

ERBB2 CACNA2D2 PGC PARD6B FASN DNAH5 VEPH1 MSLN

9.20e-0620022881ef4d5ae698fa721e0f510bf0d918bd8d3b00591
ToppCell10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

RTN3 VNN1 MGAM SYNE1 ICAM3 CR1 IFRD1 IGF2R

9.20e-062002288026495aa7f1e7528a01d9199475cfc393677fc60
ToppCellSepsis-Leuk-UTI-Lymphocyte-T/NK-MAIT|Leuk-UTI / Disease, condition lineage and cell class

ABCA2 ZNF440 CLIC5 MOK SYNE1 DUSP8 DDX56 TGFBR3

9.20e-0620022887e0d0f051c197c2c70080f039e1c4dd68db8e74f
ToppCellfacs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C3AR1 MOK SEMA4B ANK2 DUSP8 THAP12 ARHGAP19

1.36e-051522287b61d2f6ee819c8dd4b4b601a8bc8388b1983de58
ToppCellNS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MAP1A DNAH6 MOK CCDC73 STIL SYT10 HYDIN

1.67e-051572287410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

BCAT1 ME1 PARD6B CLIC5 VEPH1 TGM1 MSLN

1.67e-0515722879665a1375cfd8e9b8781c852686591226c0e0d9a
ToppCellfacs-Marrow-B-cells-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYLK3 HEBP1 RAD23A DUSP8 HECTD4 RNF123 ABCB10

2.22e-05164228718eeda51e69722992c3a7f699be293535a90868b
ToppCellPND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass

TRPM6 PRRG2 PARD6B CLIC5 SLC1A6 ARHGEF26 MSLN

2.31e-051652287b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637
ToppCellP15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MAP1A PIK3C2B SV2A EXOG NT5E HEATR1 ACTR6

2.49e-0516722875c3d0763f73628c71c71f9883556bb4f1639f3cc
ToppCelldroplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TRPM6 MIS18BP1 TINAGL1 SMG7 PIK3C2B PARP9 ENG

2.49e-051672287774f3264318b002d0df5d06d41d645366038d0bf
ToppCelldroplet-Kidney-KIDNEY-1m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC17A3 CYP2E1 TTC36 ME1 TMIGD1 TGM1 AACS

2.59e-051682287624cf8f439c0a3c877927e085ec260ca79896b5a
ToppCellControl|World / group, cell type (main and fine annotations)

CACNA2D2 ADGRV1 PGC KANK1 SYNE1 VEPH1 MUC5AC

2.59e-051682287a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCellfacs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYLK3 HEBP1 RAD23A DUSP8 HECTD4 RNF123 ABCB10

2.59e-05168228708fe8fa43c343c03f9a2f0b982192fde04a7c027
ToppCellfacs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYLK3 HEBP1 RAD23A DUSP8 HECTD4 RNF123 ABCB10

2.59e-051682287d4053b2fffb19e0376b8ceb92e87ec4447d96a3e
ToppCellPND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MIS18BP1 PIK3C2B MKI67 TCTN1 PML STIL ARHGAP19

2.79e-051702287e08a6c5ac34c456da8c7318f104e06fca585be1f
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA2D2 PARD6B NRSN2 SNAP91 VWA7 SLC1A6 ENO2

2.90e-05171228799176a932569fa1c7e1c01009684f5a65244b96e
ToppCell367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SYCP2L PARD6B VNN1 DSC3 MUC16 TGM1 MSLN

3.12e-0517322873d7c281a1a9f183a5a861d1a9c7b50d216535893
ToppCell367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SYCP2L PARD6B VNN1 DSC3 MUC16 TGM1 MSLN

3.12e-0517322873aa90578371039f81b7c6fa873ec70f8f2bc7dfa
ToppCell390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

FCGBP RIN2 C3AR1 SDR42E1 E2F3 HIVEP3 ENG

3.12e-0517322871f725ff16e28636b20ef26f3fa9be8b47c89378d
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PGR TINAGL1 C9orf43 SYNE1 ADGRA2 CSPG4 ENG

3.36e-05175228712f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCellNS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ME1 PGR NT5E STIL ADGRA2 CENPI MSLN

3.49e-0517622877cf1a06ceee1ec06532f44c729c31b4d58e5ea49
ToppCellCV-Severe-7|CV / Virus stimulation, Condition and Cluster

ME1 LYST HEATR1 HUWE1 ANKRD44 BCO2 ZBED6

3.49e-0517622873de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCellControl-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO9A BCAT1 ME1 PARD6B CLIC5 VEPH1 ARHGEF26

3.61e-0517722879af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCellB_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis

PRRG2 CIITA PIK3C2B A4GALT IQSEC1 HECTD4 HIVEP3

3.75e-05178228771ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MAP1A ABCA13 SSRP1 ZNF440 LRRC14B STIL SYT10

3.88e-051792287d15182c668d7c37be8214cad9f1fe35d1409c9a1
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MAP1A ABCA13 SSRP1 ZNF440 LRRC14B STIL SYT10

3.88e-051792287e22a275a7c0ed19113c833a75d6c49fcc19aa13a
ToppCellCOVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type

STARD13 PGR TINAGL1 LRRC75A ADGRA2 CSPG4 ENG

3.88e-051792287342c1cc4444f51b8dcb30d3adc98285a25669c6e
ToppCellCiliated_cells-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

MAP1A ABCA13 USP20 C9orf43 DNAH6 TCTN1 TLCD3A

3.88e-0517922871c41314b6fcfcac8d62034e7037570120d58f20f
ToppCell5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MAP1B DSC3 MUC16 NR2F1 TGM1 BCO2 MSLN

4.17e-05181228765eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c
ToppCell5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MAP1B DSC3 MUC16 NR2F1 TGM1 BCO2 MSLN

4.17e-051812287eaac7d58117eddfff06b25521efc431c1351d592
DiseaseCiliopathies

CDH23 ADGRV1 DNAH5 TCTN1 BBS5 NEK8 RPE65

1.93e-051102207C4277690

Protein segments in the cluster

PeptideGeneStartEntry
TNENVILTPGPAFRF

NT5C1B

341

Q96P26
AVPEILFNPSDIGIQ

ACTR6

276

Q9GZN1
FVVIQNEDLGPASPL

ERBB2

986

P04626
FEFIFTNLVPGSPRL

BBS5

106

Q8N3I7
PDISPLQSFELGIAN

CFAP97

261

Q9P2B7
NAELAQLFPGSVIDP

BIRC6

1721

Q9NR09
KPDPNNLVFGTVFTD

BCAT1

41

P54687
AAIPLEAQNFSVPEG

CSPG4

1356

Q6UVK1
PQTTNFREPVTLDFL

CACNA2D2

566

Q9NY47
PGNIFFLETSDRTNP

A4GALT

76

Q9NPC4
GTSEQAPQLEFEQLP

AACS

266

Q86V21
NIFSSLQPGVFDELP

ADGRA2

166

Q96PE1
SLGPQPLVAADEVFS

CIITA

471

P33076
PSISPNFNFLGQLLE

DUSP8

281

Q13202
FLQQAQPLLETEAPG

DUX4L4

381

P0CJ87
QALNFTRFLDQSGPP

AKAP13

111

Q12802
PLEDFEPVQNGELFF

ADGRV1

5051

Q8WXG9
SGSFFQPILAPCELE

DPH2

351

Q9BQC3
FLLLGADPSPENDVF

ABCA13

596

Q86UQ4
EVPIFQDFSLSIPSG

ABCB10

506

Q9NRK6
QLQVFTFFPESLPAT

DNMBP

1231

Q6XZF7
QSPNGLLITDFPVED

ARHGEF26

41

Q96DR7
ETFIPLLLQNPQDGF

AQR

1071

O60306
LRFPNGVQLSPAEDF

APMAP

256

Q9HDC9
NLLQPNFEAAFGTTP

SNAP91

691

O60641
LDINDNAPIFVSTPF

CELSR2

496

Q9HCU4
PSDLVFSQELILGPN

DNHD1

2816

Q96M86
PGQPVTFSEEVFLAQ

DENND1C

351

Q8IV53
FVLPLNVSLNAPEGD

BCO2

411

Q9BYV7
GQFTDDDQVPTPLVA

C3AR1

321

Q16581
NDPTFQNLPFVAEVL

CDH23

886

Q9H251
PPFLTFNGDVKTDVN

CLIC5

231

Q9NZA1
SDLILPVPAFNVING

ENO2

141

P09104
VLFLEFPTGPSQLEL

ENG

66

P17813
VQQLPGEFFSLENPS

ACRV1

36

P26436
FELPQTPLATSFEGR

ARRDC3

116

Q96B67
SAVPEQPLDVTANGF

ADAT1

401

Q9BUB4
ALLEEVDPNPANFVG

AP2A2

876

O94973
TLPFEAVLQNLFPSQ

RAI2

181

Q9Y5P3
QPATEAAGENPLEFL

RAD23A

221

P54725
VEDSFDPNINPTIGA

RAB22A

26

Q9UL26
EALRKTQGQPFDPTF

CYP2E1

156

P05181
NIPFFPDLQITDQVS

NR2F1

236

P10589
VFPLPEPQDFFLASQ

FMN1

1246

Q68DA7
EAPVQVAEGLTLPQF

GLRA3

206

O75311
GVIEAFPPADNVTNL

IQCH

741

Q86VS3
QFSPDDFLGRTEIPV

ITSN2

1641

Q9NZM3
IPALSSGIFQFPLNL

PARP9

236

Q8IXQ6
NSLLGYPQQIEPSFE

PARD6B

271

Q9BYG5
LFRQVQSEIPGSPIF

ACACB

476

O00763
EGTPTSEQNPFLFQE

ANK2

3091

Q01484
PFSPGLFADQAEILL

NUP210

1686

Q8TEM1
EFSPAAFEQEQLGSP

MAML1

301

Q92585
GPLLVPFTLNFTITN

MUC16

12851

Q8WXI7
SQLAIIPQEPFLFSG

ABCC10

1321

Q5T3U5
IPQEPFLFSGTVREN

ABCC10

1326

Q5T3U5
FSFLQATLALNPEDP

MEGF11

11

A6BM72
VPTVSGFLLSQDPEF

SLC17A3

366

O00476
PPGTVIALFQVFDRD

PCDHGA6

361

Q9Y5G7
AGELPLEPEQFLASQ

LRRC37A3

116

O60309
AFNERPIIFALSNPT

ME1

396

P48163
NLISPELGVVFFNVP

MAP1A

126

P78559
SPDLGVVFLNVPENL

MAP1B

351

P46821
GVPLESSNNDIFLPV

MIS18BP1

186

Q6P0N0
TQSPFEGFPQSVLQI

MAGEC1

151

O60732
AQSTFEGFPQSPLQI

MAGEC1

361

O60732
FPQSPLQGEEFQSSL

MAGEC1

611

O60732
GSAVPNSFPEVVELN

KCTD16

16

Q68DU8
PVFEQFPLVDGTLFL

HECA

406

Q9UBI9
FQEFLPSLNSSPLDI

GMIP

366

Q9P107
LNSLQDFQPELFGLP

PUDP

211

Q08623
VPLFLDGNVSFLPEN

MMS19

681

Q96T76
SQVGDLAFPRFEIPA

HMX3

86

A6NHT5
IDLGNNVDIFSLPQP

LRRC75A

266

Q8NAA5
LFTITDQENNPALPG

AQP7B

191

A0A075B734
IQSLFPNLQVFPALG

SMPDL3A

136

Q92484
DSQFLLGPAFLVSPV

MGAM

1651

O43451
IDSQFLLGPAFLVSP

MGAM

2546

O43451
AGSLESNVEFQPFEP

IQSEC1

941

Q6DN90
NPGIVLTFVLPTEQF

DDX56

381

Q9NY93
TVLDGLPFFSVDPQT

CDH24

191

Q86UP0
PQALDAEFQDIPSFP

PNMA6F

91

A0A0J9YX94
NSDAVEPIFILRGFP

OR51L1

6

Q8NGJ5
TNDSELQVPLFITFP

OR5B3

16

Q8NH48
VNFGTPEFLAPEVVN

MYLK3

671

Q32MK0
VNFGTPEFLSPEVVN

MYLK2

441

Q9H1R3
LPFTSAFLPAVNEVD

NAA16

831

Q6N069
VSEQNAPAPFLGIVD

FAM214B

396

Q7L5A3
FLFQQSLFPEPLSIQ

VEPH1

621

Q14D04
PQPQFISRFLEGQSG

NEK8

376

Q86SG6
DAFPTQEGTLSPVNL

KANK1

941

Q14678
QVSTPLFGSFDPDIQ

LRRC14B

471

A6NHZ5
DLLLFLNPDAFSGPQ

MSLN

121

Q13421
VPNEAIGFQPQLTEF

EXOG

251

Q9Y2C4
ASLQPLFPGVNELDQ

MOK

196

Q9UQ07
SFPNTPLADLGQDVI

MUC5AC

2001

P98088
LTDQPPLVQAIFSGD

ANKRD44

6

Q8N8A2
VPEDLAGFIELFQTP

MKI67

1706

P46013
VFGDEPEQQLSPIFR

NRSN2

161

Q9GZP1
GLPIRPEQQAVFFAL

OR1J1

16

Q8NGS3
IFLNISDVNDNPPSF

PCDHGC4

441

Q9Y5F7
VVFDSPRNGELQDFP

PADI3

366

Q9ULW8
FLQTAPEQFPSEEFP

HECTD4

2561

Q9Y4D8
NPGVTEVSPEFLAAL

HUWE1

3011

Q7Z6Z7
VFSFLGPIVNLSEPT

ICAM3

311

P32942
PSDINTFSLVEQLPG

PIK3C2B

186

O00750
IPEGLFTPDNFQALL

THAP12

191

O43422
QRFTFSPGQDIQLIP

PGR

671

P06401
VVSGPDPVNTVFLNF

PLCB3

106

Q01970
VEDFLPFLTNPNTGD

OTUD6B

191

Q8N6M0
AFVQPGPVSLVDELN

CHD9

26

Q3L8U1
IFQAILNGFLSDFPP

DNAH6

2246

Q9C0G6
VVVADLFDQTFGPPN

HIP1R

331

O75146
PPLSIEDLGLNFQFC

HECTD1

2401

Q9ULT8
VPFLDIQTPDFEGLS

HYDIN

2566

Q4G0P3
QFETLEPPAAPENFI

IDNK

151

Q5T6J7
EDQIPSNLEGPFVNL

E2F3

411

O00716
ILFDISSPAQTIPEG

SDR42E1

36

Q8WUS8
ENSLGPFPLFLQQVE

DSC3

146

Q14574
PFPLFLQQVESDAAQ

DSC3

151

Q14574
NIPSGIFNIIPSTFL

CAPN7

776

Q9Y6W3
QFPFASPTIPINDFE

CR1

1401

P17927
PPLGAENFTVTVANE

FCGBP

3306

Q9Y6R7
LPNFGFVVFDDSEPV

G3BP2

371

Q9UN86
FNPEPLVLQSFPSDE

DIPK2A

211

Q8NDZ4
PVQLSEQFSSDFLPL

C9orf43

191

Q8TAL5
AGVDDFFIPPTNLII

FSTL4

591

Q6MZW2
SENEPFKQFRLLPGT

CCDC73

596

Q6ZRK6
ANPEIPLGSAEQFLL

FHOD3

1021

Q2V2M9
PFLLELSESQAGEPF

DNAAF9

251

Q5TEA3
LESFTQGLPLSNFVP

ABCA2

1576

Q9BZC7
PPFSVENGTSFLENV

SLC1A6

226

P48664
LDSFGELIPQPSNEV

EPHA3

16

P29320
SNLAPGTLDQPIVFD

CAPRIN2

1006

Q6IMN6
GSPPDLELLTIIFNF

LYST

2001

Q99698
SNEFLRNVFELGPPV

IFRD1

391

O00458
PFLDENVVSFLNSLP

ASNSD1

551

Q9NWL6
AELFESLQEQPGALP

DENND4B

711

O75064
QPISTFGNFKALPLE

FBXO47

36

Q5MNV8
EAFVQALQIPDGPTS

IPO9

246

Q96P70
EQFLELSYLNGVPEP

KHDRBS1

266

Q07666
DPLAFTDVFVALGPQ

HAPLN4

91

Q86UW8
IQIDPNGLSFNPISD

KNG1

591

P01042
LGIDPSFEQFEAPLF

HEATR1

56

Q9H583
SGPLTFSEQLQEFQP

FAM186A

1876

A6NE01
SGSFPLEQLQSFPQL

CENPI

336

Q92674
NVPDPVFESILTGSF

GPATCH2

316

Q9NW75
ISGPQAPVFEFVEQL

FASN

651

P49327
LELLPLQNGNFVPFS

SACS

666

Q9NZJ4
PSFISGNDILCIFDP

SACS

2636

Q9NZJ4
VFPILNTLENSPESF

METTL8

211

Q9H825
NDGFGTILPLETLQF

CFAP74

966

Q9C0B2
ALDFSLLNPNGPFVL

CFAP74

1276

Q9C0B2
NIDEGPLAFATPEQI

DHX9

346

Q08211
PGTGELFVNFDPQIL

DNAH5

701

Q8TE73
AAFTVSLDPGPLEQF

MRTO4

131

Q9UKD2
LPSFNQLFGLSDPVN

PPM1F

176

P49593
SAPPEQQQSLFGIFL

OR1N1

16

Q8NGS0
TDDPLGLPVSFFTQQ

FREM3

366

P0C091
SDGINFSPNVFFPII

FREM3

1171

P0C091
SNPIEIDFQTSGPIF

PTGFRN

676

Q9P2B2
IRDPNSGFVFNLNPL

IGF2R

936

P11717
LLQENSPLIGDFPAF

RTL1

256

A6NKG5
EFDIVPSPNFSVVLG

RTL1

491

A6NKG5
NTIPAQELAELFLGP

RTL1

1156

A6NKG5
FPTQGTPVASLDLEQ

RTN3

726

O95197
EVLFSGPRQAFEFPQ

RPE65

406

Q16518
FPSPNQITLDFEGNS

STARD13

526

Q9Y3M8
GEPFVLQQAVPVDLF

TRMT2B

476

Q96GJ1
VLNPGEVLPTAFEAS

TINAGL1

196

Q9GZM7
PGTVNIPFTDFLSQE

MPST

206

P25325
QEDAFVSVLNPGELP

SMYD4

261

Q8IYR2
PSNFLEIDIFNPQTV

SNX12

26

Q9UMY4
DEILPGFPSFANSVQ

SYNE1

296

Q8NF91
LSPDFPEQQAFLTQP

RFFL

151

Q8WZ73
PEENFFNVPAFLTVS

NARS2

206

Q96I59
PLGADTPALDNVFFE

PML

96

P29590
SATPLPEEFELQGFL

SMG7

411

Q92540
QPPEATLRAGELSFF

NAGPA

431

Q9UK23
SRPDDGFPFNVLQDV

SEMA4B

311

Q9NPR2
GFPFNVLQDVFTLSP

SEMA4B

316

Q9NPR2
GLPPDFLDSEVNLFL

SMG9

416

Q9H0W8
FLPPGTQAEFNLRDI

SHBG

226

P04278
AALQEQVFSELGFPP

SHARPIN

251

Q9H0F6
AEPIFIDANFQSTVP

SURF1

241

Q15526
LPAVAFNVNNLPFTE

HERC2P3

976

Q9BVR0
ILNPVAIPEGQFIDS

MYH6

726

P13533
GDPFSADDILFPVLQ

ARHGAP35

791

Q9NRY4
LTTQPESPRFFLENG

SV2A

351

Q7L0J3
FDIGDQPVFEIPLSN

SSRP1

121

Q08945
ALFQPLTPGSREFED

TASOR

111

Q9UK61
QIFLLDEPTAGLDPF

ABCA8

636

O94911
TPFLSNPGTNLVFED

NT5E

181

P21589
ETFSAILTLEGPPQQ

CHRD

281

Q9H2X0
FDGQPINETDTPAQL

SUMO3

61

P55854
LDFSQLFNFIPLNGP

PLAG1

416

Q6DJT9
VPPQLIFSSFIQEGL

TIGD3

351

Q6B0B8
EAAEVLQAQPPGIFL

RIN2

106

Q8WYP3
QPSVPELSLVLDGNF

STIL

421

Q15468
GETFTPVPDDRLNFQ

ZNF440

81

Q8IYI8
VLNVTFPPLLSGNDF

TMIGD1

116

Q6UXZ0
FPPLLSGNDFQTVEE

TMIGD1

121

Q6UXZ0
VFPEVLLSENQLAPG

VNN1

436

O95497
PFTPVQLFAGEEITV

TRPM6

1726

Q9BX84
ELSPELFESPNIQFF

RALGAPA1

1546

Q6GYQ0
SIINDISGEPENFPA

SPEN

2221

Q96T58
LEDAPVSIANPFTNG

MKRN2OS

41

H3BPM6
EISIGTPPQNFLVLF

PGC

76

P20142
PNLTADVGFIDSFRP

SEC62

266

Q99442
PGRPTALFQLEDEQF

SH2D3A

71

Q9BRG2
ALFQLEDEQFPSIPA

SH2D3A

76

Q9BRG2
ADLLQQGPDVAPSFL

RNF123

1016

Q5XPI4
PGNITFVPINSVDLD

SP3

261

Q02447
VPENLNGSAILPTFE

SYCP2L

696

Q5T4T6
QQGLSLLQVPFSIPF

TLCD3A

206

Q8TBR7
LEPPSEFGDLQFCLS

SYT15B

326

X6R8R1
TDQEVFLGPPEAQSF

PRRG2

26

O14669
ALSFINPEVPDENNF

TCTN1

161

Q2MV58
PLQSQFALQLPGDVE

HIVEP3

1241

Q5T1R4
PLLPGITFTNNQLFF

PHEX

671

P78562
LNAPGENILFFPVSI

SERPINA13P

66

Q6UXR4
DIPFLSPTFNPQEVF

ACP6

146

Q9NPH0
EEFGNLTPEQLAAPI

POLR3B

6

Q9NW08
SSLRGQPIIFNPDFF

ARHGAP19

31

Q14CB8
AFLNENLPESIFGAP

SF3B3

841

Q15393
TLNPLFDETFQFPVA

SYT10

291

Q6XYQ8
NTFAEPGPITNQTFL

USP20

721

Q9Y2K6
DFTPLIENPSATGEF

ZNFX1

556

Q9P2E3
DEESLQLGNFPEPLF

ZBTB1

176

Q9Y2K1
DFNQLDGPTRIIVPF

FTSJ1

221

Q9UET6
PISFGIDQILNSPDQ

TLX1

16

P31314
LSPNFLIPSFIVSDN

ZBED6

551

P86452
DQAVLQAIFNPDTPF

TTC36

6

A6NLP5
AFFGPSSINEIEILP

ZGRF1

1501

Q86YA3
TQSDAGEFQLPFDPR

TGM1

226

P22735
FETPEIFRPEGILSQ

USP31

396

Q70CQ4
FSGPQDLDLRTFVNP

VWA7

751

Q9Y334
DLFLVPSQGVFSVPE

TGFBR3

601

Q03167
FELQPQEPNSFFDGI

ZFY

6

P08048
GETFTPVPDDRLNFQ

ZNF439

96

Q8NDP4
TPPFSGVEFSEEQLQ

VPS13D

791

Q5THJ4
PISFAVFPNEDGSLQ

HEBP1

81

Q9NRV9
LEDKPQFISRGTFNP

MYO9A

2481

B2RTY4